These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1341975)

  • 1. New concepts in the relationship obesity--non-insulin dependent diabetes mellitus.
    Björntorp P
    Eur J Med; 1992 Apr; 1(1):37-42. PubMed ID: 1341975
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms linking obesity to insulin resistance and type 2 diabetes.
    Kahn SE; Hull RL; Utzschneider KM
    Nature; 2006 Dec; 444(7121):840-6. PubMed ID: 17167471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body fat distribution and the risk of non-insulin-dependent diabetes mellitus in the Omani population.
    al-Asfoor DH; al-Lawati JA; Mohammed AJ
    East Mediterr Health J; 1999 Jan; 5(1):14-20. PubMed ID: 10793776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity: the two faces of fat.
    Powell K
    Nature; 2007 May; 447(7144):525-7. PubMed ID: 17538594
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum sex-hormone-binding globulin is related to hepatic and peripheral insulin sensitivity but not to beta-cell function in men and women with Type 2 diabetes mellitus.
    Laing I; Olukoga AO; Gordon C; Boulton AJ
    Diabet Med; 1998 Jun; 15(6):473-9. PubMed ID: 9632121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of obesity-induced insulin resistance and type 2 diabetes mellitus.
    Tataranni PA
    Eur Rev Med Pharmacol Sci; 2002; 6(2-3):27-32. PubMed ID: 12708607
    [No Abstract]   [Full Text] [Related]  

  • 7. Androgens, insulin resistance and vascular disease in men.
    Kapoor D; Malkin CJ; Channer KS; Jones TH
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):239-50. PubMed ID: 16117808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors.
    Hernández-Mijares A; Jarabo-Bueno MM; López-Ruiz A; Solá-Izquierdo E; Morillas-Ariño C; Martínez-Triguero ML
    Int J Obes (Lond); 2007 Jun; 31(6):927-32. PubMed ID: 17264851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The road from obesity to type 2 diabetes.
    Ioannidis I
    Angiology; 2008; 59(2 Suppl):39S-43S. PubMed ID: 18505743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of obesity and risk of non-insulin-dependent diabetes mellitus.
    Sakurai Y
    Biomed Pharmacother; 2000 Mar; 54(2):80-4. PubMed ID: 10759291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The origins and consequences of obesity. Diabetes.
    Björntorp P
    Ciba Found Symp; 1996; 201():68-80; discussion 80-9, 188-93. PubMed ID: 9017275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity upregulates genes involved in oxidative phosphorylation in livers of diabetic patients.
    Takamura T; Misu H; Matsuzawa-Nagata N; Sakurai M; Ota T; Shimizu A; Kurita S; Takeshita Y; Ando H; Honda M; Kaneko S
    Obesity (Silver Spring); 2008 Dec; 16(12):2601-9. PubMed ID: 18846047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipotoxicity and the insulin resistance syndrome.
    Anderwald C; Roden M
    Pediatr Endocrinol Rev; 2004 Mar; 1(3):310-9. PubMed ID: 16437024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of metformin vs. placebo treatment on serum fatty acids in non-diabetic obese insulin resistant individuals.
    Rodríguez Y; Giri M; Feyen E; Christophe AB
    Prostaglandins Leukot Essent Fatty Acids; 2004 Dec; 71(6):391-7. PubMed ID: 15519498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of obesity-associated insulin resistance: many choices on the menu.
    Qatanani M; Lazar MA
    Genes Dev; 2007 Jun; 21(12):1443-55. PubMed ID: 17575046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance and androgens in healthy women with different body fat distributions.
    Ivandić A; Prpić-Krizevac I; Bozić D; Barbir A; Peljhan V; Balog Z; Glasnović M
    Wien Klin Wochenschr; 2002 May; 114(8-9):321-6. PubMed ID: 12212367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of free fatty acids in the development of Type 2 diabetes.
    Wilding JP
    Diabet Med; 2007 Sep; 24(9):934-45. PubMed ID: 17725706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between intra-abdominal fat and hypertension in android obese diabetics.
    Sepulveda-Lavados A; Bastard JP; Attal M; Belin MF; Sachon C; Verny C; Grimaldi A
    Ann Med Interne (Paris); 1996; 147(6):393-16. PubMed ID: 9092341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
    Annuzzi G; Giacco R; Patti L; Di Marino L; De Natale C; Costabile G; Marra M; Santangelo C; Masella R; Rivellese AA
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):531-8. PubMed ID: 18321693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.